Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Canepa

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Acta Haematologica|January 1, 1981
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the diseaseG L Bianchi ScarrĂ , F Ajmar, R Barresi, et al.
European Journal of Haematology|January 1, 1989
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemiaC Melani, L Canepa, M Sessarego, et al.
Journal of Clinical Pharmacology|August 1, 1982
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjectsT Meloni, G Forteleoni, M Serra, et al.
Blood|July 1, 1983
Reexpression of normal stem cells in erythroleukemia during remissionA M Ferraris, L Canepa, C Mareni, et al.
British Journal of Haematology|November 13, 2001
Thalidomide in agnogenic and secondary myelofibrosisL Canepa, F Ballerini, R Varaldo, et al.
Haematologica|May 1, 1994
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicityM Spriano, M Clavio, P Carrara, et al.
American Journal of Hematology|September 1, 1985
Clonal development from a progenitor with restricted differentiative expression in acute lymphoblastic leukemiaA M Ferraris, L Canepa, L Massimo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2001
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR methodM Miglino, R Grasso, D Pietrasanta, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimensM Clavio, S Quintino, B Masoudi, et al.
Haematologica|July 17, 2001
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantationM Miglino, G Santini, R Grasso, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Acta Haematologica|January 1, 1981
Urinary granulopoietic activity in chronic myelogenous leukemia: follow-up and correlation with various phases of the diseaseG L Bianchi ScarrĂ , F Ajmar, R Barresi, et al.
European Journal of Haematology|January 1, 1989
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemiaC Melani, L Canepa, M Sessarego, et al.
Journal of Clinical Pharmacology|August 1, 1982
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjectsT Meloni, G Forteleoni, M Serra, et al.
Blood|July 1, 1983
Reexpression of normal stem cells in erythroleukemia during remissionA M Ferraris, L Canepa, C Mareni, et al.
British Journal of Haematology|November 13, 2001
Thalidomide in agnogenic and secondary myelofibrosisL Canepa, F Ballerini, R Varaldo, et al.
Haematologica|May 1, 1994
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicityM Spriano, M Clavio, P Carrara, et al.
American Journal of Hematology|September 1, 1985
Clonal development from a progenitor with restricted differentiative expression in acute lymphoblastic leukemiaA M Ferraris, L Canepa, L Massimo, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 24, 2001
Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR methodM Miglino, R Grasso, D Pietrasanta, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 4, 2001
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimensM Clavio, S Quintino, B Masoudi, et al.
Haematologica|July 17, 2001
Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantationM Miglino, G Santini, R Grasso, et al.
Pageof 3